How Do Hypertrophic Scars And Keloids Differ In Laser Treatment Response? Optimize Your Aesthetic Outcomes By Understanding The Key Histological And Clinical Differences.

Hypertrophic scars generally respond more predictably to aesthetic laser treatment than keloids. Their confinement to the original wound, organized collagen structure, and greater vascularity make them more responsive to vascular lasers and collagen-remodeling approaches. Keloids extend into surrounding skin and contain dense, disorganized, relatively less vascular collagen, so they often require more sessions, combination therapy, and stricter recurrence precautions.

Scar classification determines treatment expectations: vascular and remodeling lasers may produce substantial improvement in hypertrophic scars, while keloids are biologically more persistent and may respond incompletely to laser treatment alone.

Why the Two Scars Behave Differently

Hypertrophic Scars Remain Within the Wound

Hypertrophic scars stay within the boundaries of the original injury. They commonly develop within weeks of wound closure and may gradually flatten or regress over time.

Clinically, they are often raised, firm, pink or red, and associated with tension across the healing wound. Their natural tendency toward regression is an important advantage when evaluating expected treatment outcomes.

Keloids Expand Beyond the Injury

Keloids grow beyond the original wound margins into previously normal skin. They may arise months or years after an injury, and they rarely regress spontaneously.

They can be firm, shiny, tender, itchy, or nodular. Their continued growth and tendency to recur after trauma make treatment planning more complex.

Their Collagen Architecture Is Different

Hypertrophic scars contain relatively organized collagen fibers, a scant mucoid matrix, and a comparatively vascular base. This structure provides both a vascular target and a more accessible substrate for collagen remodeling.

Keloids contain thick, haphazardly arranged, hyalinized collagen within a prominent mucoid matrix. The tissue is generally less vascular than an early hypertrophic scar, which can reduce the effectiveness of vascular hypoperfusion alone.

How Histology Influences Laser Response

Vascular Lasers Favor Red, Vascular Scars

Vascular-targeting systems, such as pulsed dye lasers, are most useful when erythema and superficial vascularity are prominent. In hypertrophic scars, selective vascular injury can reduce redness and may contribute to softening and improved pliability through subsequent remodeling.

This is why vascularized hypertrophic scars often show meaningful improvement after a limited number of sessions. Depending on scar age, size, vascularity, and treatment parameters, reported improvement may reach approximately 50% to 80% across texture, redness, thickness, and pliability.

Dense Keloid Tissue Limits Vascular Treatment Alone

A mature keloid may have a less prominent vascular base and a large burden of dense collagen. Treating its vessels alone may therefore reduce redness without adequately changing the bulk, firmness, or continued proliferative behavior of the lesion.

Small or active keloids can still show benefit from vascular lasers, particularly when erythema or telangiectasia is present. However, the response is generally less predictable than with hypertrophic scars.

Remodeling Technologies Address Different Tissue Features

Fractional non-ablative or ablative lasers can create controlled zones of injury that stimulate remodeling within thickened scar tissue. These approaches may be considered for selected mature scars, especially when texture and rigidity are the dominant concerns.

They do not eliminate the underlying tendency toward keloid formation. Treatment must therefore be individualized, conservative, and often combined with other therapies.

Clinical Differences That Change Treatment Planning

Natural History Sets Different Expectations

A hypertrophic scar may improve even without intervention, so laser treatment can accelerate or enhance a process that is already moving toward flattening. A keloid usually requires a strategy aimed at controlling persistent disease rather than simply improving residual texture.

This distinction affects the number of sessions, follow-up period, and definition of success. For keloids, stabilization and symptom reduction may be more realistic initial goals than complete removal.

Location and Tension Affect Risk

Keloids are particularly concerning in high-tension areas such as the presternal chest, shoulders, and upper back. Additional tissue injury in these regions may stimulate further growth or recurrence.

Hypertrophic scars can also worsen under tension, but their confinement and tendency to regress generally make procedural escalation less hazardous than it is for a confirmed keloid.

Skin Phototype Requires Additional Precautions

Keloids occur more frequently in darker skin phototypes, where laser procedures also carry greater risk of post-inflammatory hyperpigmentation. This makes wavelength selection, fluence, pulse duration, cooling, test spots, and sun protection important parts of treatment planning.

The risk is not limited to pigmentary change. Excessive thermal or mechanical injury may also provoke renewed scar activity in a keloid-prone patient.

Why Combination Treatment Is Often Necessary

Keloids May Need Intralesional Therapy

Because keloids are driven by persistent abnormal scar biology, laser treatment alone may be insufficient. Intralesional corticosteroids are commonly used as an adjunct to reduce thickness, inflammation, symptoms, and recurrence risk.

Other adjunctive approaches may include silicone sheeting, pressure therapy, or carefully selected surgical management. The appropriate combination depends on lesion size, activity, location, symptoms, and recurrence history.

Laser Choice Should Match the Dominant Problem

A red, relatively early hypertrophic scar may be approached with a vascular laser. A mature, firm scar with substantial textural abnormality may require a remodeling-focused modality.

For a keloid, vascular or fractional treatment may be used selectively, but usually within a broader protocol. The choice should reflect whether the primary issue is erythema, pruritus, thickness, pain, stiffness, or ongoing expansion.

Treatment Timing Matters

Early, vascularized hypertrophic scars may respond particularly well to vascular treatment. Mature scars with dense collagen may require more sessions and a longer interval for remodeling to become clinically apparent.

An enlarging or symptomatic keloid should be assessed for active disease before elective resurfacing or microneedling-based treatment is considered.

Understanding the Trade-offs

More Aggressive Treatment Is Not Automatically Better

Higher fluence, deeper ablation, or more extensive mechanical injury may increase remodeling but also increase inflammation, pigmentary complications, delayed healing, and scar stimulation.

This trade-off is especially important for keloids. A cautious, staged protocol is usually more defensible than a single aggressive procedure.

Laser Treatment Does Not Remove Recurrence Risk

A keloid can recur after laser treatment, surgery, or other interventions. Improvement in visible thickness or redness does not necessarily mean that the underlying tendency has been corrected.

Patients should be counseled that long-term monitoring and adjunctive treatment may be necessary.

Diagnosis Must Precede Modality Selection

A raised scar should not automatically be labeled hypertrophic or treated as a routine resurfacing case. Extension beyond the wound, progressive enlargement, delayed onset, symptoms, location, and prior recurrence all help determine whether keloid biology is likely.

When the diagnosis is uncertain, specialist assessment is preferable to proceeding with an aggressive energy-based procedure.

Making the Right Choice for Your Goal

The safest treatment plan begins with accurate classification and a realistic definition of improvement.

If your primary focus is reducing redness in an early hypertrophic scar: A vascular-targeting laser may be appropriate because the lesion commonly has a stronger vascular component and a more predictable response.
If your primary focus is improving thickness and texture in a mature scar: A remodeling-focused fractional approach may be considered, with parameters selected according to scar maturity, location, and skin phototype.
If your primary focus is treating a confirmed keloid: Expect a longer, multimodal treatment course that may combine carefully selected laser therapy with intralesional or pressure-based interventions.
If your primary focus is minimizing recurrence: Avoid unnecessarily aggressive injury, assess high-risk anatomy and skin phototype, and include ongoing follow-up in the treatment plan.

Understanding whether the lesion is a regressing hypertrophic scar or a persistent keloid is the foundation for choosing laser treatment that is both effective and appropriately cautious.

Summary Table:

Feature	Hypertrophic Scars	Keloids
Extent	Confined to original wound	Extend beyond wound margins
Natural History	May regress over time	Rarely regress; persist
Collagen Structure	Organized fibers	Disorganized, hyalinized
Vascularity	More vascular	Less vascular
Laser Response	More predictable	Less predictable; require combination therapy
Recurrence Risk	Lower	Higher

Unlock the full potential of your aesthetic laser practice with BELIS. Our professional-grade devices—from vascular lasers to fractional CO2—are designed to deliver superior results for hypertrophic scars and keloids. Whether you're a clinic or premium salon, our advanced technology, combined with expert support, ensures you can offer safe and effective scar treatments. Contact us today to elevate your services and expand your clientele. Get in touch with our specialists to learn more about our OEM/ODM options and how BELIS can empower your business.